The efficacy and safety of midazolam with fentanyl versus midazolam with ketamine for bedside invasive procedural sedation in pediatric oncology patients: A randomized, double-blinded, crossover trial
- 23 April 2022
- journal article
- research article
- Published by Taylor & Francis in Pediatric Hematology and Oncology
- Vol. 39 (8) , 681-696
Abstract
Children with cancer often require sedation before undergoing invasive procedures. Fentanyl, ketamine, and midazolam are effective drugs widely used for procedural sedation. This study aimed to investigate the efficacy and safety of midazolam-fentanyl (M-F) compared with midazolam-ketamine (M-K) for bedside procedural sedation among pediatric oncology patients. A randomized, double-blinded, crossover trial was conducted among children with cancer requiring procedural sedation for invasive procedures. Patients were randomly assigned either intravenous M-F or M-K and subsequently received the alternate regimens following the crossover design of the study. The efficacy and safety of the sedations including sedation time intervals, nausea score, vomiting episodes, pain score, adverse effects, and parent’s satisfaction were evaluated. In all, 58 patients with 116 procedural sedations were enrolled. M-K provided a shorter induction time (0:58 vs. 1:23 min) (p = 0.005), but longer sedation (9:02 vs. 5:50 min) (p = 0.019) and emergence time (4:26 vs. 0:56 min) (p = 0.011) compared with M-F. Sedation routes affected the sedation time intervals. Patients had higher rates of vomiting (0, range 0–8 vs. 0, range 0–2) (p = 0.033) but experienced less pain (0 vs. 2) (p = 0.008) in the M-K group. Overall satisfaction and other adverse effects were comparable among both sedation regimens. Combined sedative drugs are recommended to improve the effectiveness of bedside procedural sedation. M-K provided shorter induction, but longer sedation and emergence time compared with M-F. These findings correlated with sedative routes. Patients receiving M-K experienced a higher rate of vomiting, but less painfulness compared with M-F. Overall satisfaction and tolerable side effects were comparable among both sedative regimens.Keywords
This publication has 41 references indexed in Scilit:
- Central or Peripheral Catheters for Initial Venous Access of ICU PatientsCritical Care Medicine, 2013
- Prospective Randomized Crossover Evaluation of Three Anesthetic Regimens for Painful Procedures in Children with CancerThe Journal of Pediatrics, 2013
- Is ethnicity associated with morphine’s side effects in children? Morphine pharmacokinetics, analgesic response, and side effects in children having tonsillectomyPediatric Anesthesia, 2012
- A Pilot Study of Ketamine versus Midazolam/Fentanyl Sedation in Children Undergoing GI EndoscopyInternational Journal of Pediatrics, 2011
- Moderate Intravenous Sedation With Fentanyl and Midazolam for Invasive Procedures in Children With Acute Lymphoblastic LeukemiaJournal of Pediatric Oncology Nursing, 2009
- The analgesic efficacy of fentanyl: Relationship to tolerance and μ-opioid receptor regulationPharmacology Biochemistry and Behavior, 2008
- Pediatric oncology sedation trial (POST): A double‐blind randomized studyPediatric Blood & Cancer, 2008
- Accuracy of the Pain Numeric Rating Scale as a Screening Test in Primary CareJournal of General Internal Medicine, 2007
- Procedural sedation for insertion of central venous catheters in children: comparison of midazolam/fentanyl with midazolam/ketaminePediatric Anesthesia, 2006
- Sedation and Analgesia for Procedures in ChildrenNew England Journal of Medicine, 2000